|
Sep 4
|
SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting
|
|
Jul 31
|
SAB BIO Appoints Lucy To as Chief Financial Officer
|
|
Jun 20
|
SAb Biotherapeutics Rebrands as SAB BIO
|
|
Feb 2
|
SAB Biotherapeutics Announces Executive Leadership Change
|
|
Nov 29
|
SAB Biotherapeutics Starts Human Clinical Trial of Diabetes Treatment
|
|
Nov 29
|
SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes
|